Nurse-Led Bedside Trunk Control Care Program
Launched by CHUNG SHAN MEDICAL UNIVERSITY · Jun 4, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new program designed to help stroke survivors improve their trunk control, which is important for sitting up and moving. The program will train nurses in rehabilitation wards on how to support patients better during their recovery. The trial is not yet recruiting participants, but it will focus on adults aged 20 and over who are currently hospitalized for stroke and are in stable condition. To be eligible, patients must have a specific score on the Trunk Impairment Scale, which measures how well they can control their trunk movements.
If you or a family member are eligible and choose to participate, you can expect to receive personalized care aimed at helping you regain strength and control in your trunk area. This trial is important because it aims to improve the quality of care provided by nurses, ultimately enhancing the recovery experience for stroke survivors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • (a) Patients hospitalized for stroke in rehabilitation or neurology wards, currently in stable condition; (b) Trunk Impairment Scale score below 21; (c) aged 20 or above; (d) patients willing to participate.
- Exclusion Criteria:
- • Patients with Trunk Impairment Scale score above 21, as this indicates that they can perform daily activities independently
About Chung Shan Medical University
Chung Shan Medical University is a distinguished academic institution dedicated to advancing medical education, research, and healthcare services. As a clinical trial sponsor, the university leverages its expertise in medical sciences and innovative research methodologies to conduct rigorous and ethically sound clinical studies. With a commitment to enhancing patient care and contributing to the global body of medical knowledge, Chung Shan Medical University collaborates with healthcare professionals and research institutions to explore new therapeutic interventions and improve clinical outcomes. Through its comprehensive approach to research, the university plays a pivotal role in fostering advancements in medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taichung, , Taiwan
Patients applied
Trial Officials
Hsiang Chu Pai, PhD
Principal Investigator
Chung Shan Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported